Supreme Court Limits Patent Infringement Liability for “Skinny Label” Generic Drugs

Source-supplied fields

Report metadata

Identifier

LSB11462

Version

1

Product type

Posts

Status

Active

Published

Jul 27, 2026

Source updated

Jul 29, 2026, 12:31 pm UTC

Authors: Kevin J. Hickey

Source topics: Abbreviated New Drug Application (ANDA), Generic Drugs, Patent Law, Intellectual Property, Medical Product Regulation, Food & Drug Administration (FDA)

Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.

Structured Congress.gov references

Related federal bills

• S 43A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
  119th Congress
• HR 6485To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
  119th Congress